Average Co-Inventor Count = 11.06
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Galapagos Nv (13 from 116 patents)
2. Abbvie S.a.r.l. (8 from 15 patents)
3. Abbvie Inc. (6 from 822 patents)
4. Abbvie Overseas Sarl (5 from 5 patents)
5. Abbvie Global Enterprises Ltd. (1 patent)
19 patents:
1. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
2. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
3. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
4. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
5. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
6. 10604515 - Heteroaryl substituted pyridines and methods of use
7. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
8. 10399940 - Substituted pyrrolidines and methods of use
9. 10138227 - Heteroaryl substituted pyridines and methods of use
10. 10118916 - Modulators of cystic fibrosis transmembrane conductance regulator protein
11. 10085985 - Bromodomain inhibitors
12. 10035800 - Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
13. 9981910 - Substituted pyrrolidines and methods of use
14. 9969693 - 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use
15. 9840513 - Substituted tricyclics and method of use